RULES OF CONDUCT OF INSIDERS RESPECTING

Size: px
Start display at page:

Download "RULES OF CONDUCT OF INSIDERS RESPECTING"

Transcription

1 T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International ) you are subject, in certain circumstances, to restrictions relating to the Trading of securities of TFI International. More specifically: (i) (ii) (iii) (iv) you shall NOT Trade when you hold Material privileged information (as hereinafter defined) until two (2) business days following the announcement of the said information to the public; you shall NEVER Trade during a period commencing on the last day of a quarter until two (2) business days following the announcement of the said quarter s results to the public; you shall AVOID frequent Trading on the market in a way which leads to believe that speculation is taking place; you shall obtain the approval of TFI International before Trading in the Securities of TFI International in ALL circumstances. It is important to read the following text and to sign the declaration appearing on the last page. The Trading of Securities of TFI International by Insiders may entail, in certain circumstances, a civil or penal liability under the securities laws. 1

2 1. Definitions In this document: Insider of TFI International includes a. TransForce : itself; b. TFI International's subsidiaries (direct or indirect); c. the Senior executives of TFI International and the Senior executives of TFI International's Major subsidiaries (direct or indirect); d. the directors of TFI International and its Major subsidiaries (direct or indirect); e. a Significant shareholder of TFI International; f. the Senior executives of the company mentioned in (e) above; and g. any person who holds Material privileged information (as hereinafter defined) that is not disclosed to the public. Major subsidiaries means a subsidiary of a reporting issuer if the assets or revenues of the subsidiary represent 30% or more of the consolidated assets or revenues of the reporting issuer. Material privileged information includes the following events, insofar as this information is not announced by TFI International to the public and that it would reasonably be expected to significantly affect the market price or value of Securities or to have a significant influence on an informed investor s investment decisions: a. a change in share ownership that may affect the control of TFI International; b. a change in the corporate structure of TFI International such as a merger, amalgamation, spin-off or reorganization; c. a take-over bid or issuer bid; d. a major corporate acquisition, disposition or joint venture; e. a stock split, consolidation or other change in the capital structure of TFI International; f. the borrowing of a significant amount of funds; g. the public or private sale of additional Securities; h. the development of a new product and/or a development affecting TFI International's resources, technology, products or markets; i. the entering into or losing a significant contract; 2

3 j. quarterly or annual financial results or firm evidence of a significant increase or decrease in near term earnings prospects; k. an important change in capital investment plans or corporate objectives; l. a significant change in management; m. a significant litigation; n. a major labour dispute or a dispute with a major contractor or supplier of TFI International or of a Major subsidiary; o. an event of default under a financing or other agreement; p. a call of Securities for redemption; and q. any other development relating to the business and affairs of TFI International or of a Major subsidiary. Trading includes the following transaction: a. purchase or sale of Securities on the market; b. exercise of option to purchase Securities; c. transfer from an regular account to a registered account; d. any of the foregoing transaction described in a) to c) above if it is made in an account held in the name of a spouse or a child of the Insider and the Insider has control or has authority to give instructions over such account. Securities refers to any shares or options to purchase shares in TFI International. Senior executive is any person exercising the functions of director, officer (president, vice-president, secretary, treasurer, controller or general manager), or similar functions. Significant shareholder means a shareholder that has beneficial ownership of, or control or direction over, directly or indirectly, Securities carrying more than 10% of the voting rights attached to all Securities of TFI International or management company. 2. Rules applicable to Trading by all Insiders of TFI International Insiders of TFI International are subject, in certain circumstances, to restrictions relating to the Trading of Securities of TFI International considers it important to establish rules of conduct ensuring compliance with applicable laws with respect to Trading of its Securities by Insiders. These rules of conduct are as follows, the application of such rules being cumulative and not alternative: 3

4 2.1 The Insiders of TFI International who have access to Material privileged information respecting TFI International SHALL NOT Trade in the Securities of TFI International if they hold Material privileged information respecting TFI International until two (2) days following the announcement of the said information to the public. See item 3 for a description of what is deemed to constitute Material privileged information. 2.2 The Insiders of TFI International shall NEVER Trade during a period commencing on the last day of a quarter until two (2) days following the announcement of the said quarter s results ( quiet period ); 2.3 The Insiders of TFI International shall AVOID frequent Trading on the market in a way which leads to believe that speculation is taking place. 2.4 The Insiders of TFI International shall obtain the approval of the secretary of TFI International (Mrs. Josiane-M. Langlois (514) ) or its CEO (Mr. Alain Bédard (514) ) before Trading in the Securities of TFI International in ALL circumstances. The foregoing restrictions also apply to the exercise by an Insider of stock options of TFI International. The foregoing rules are made to assist the Insiders of TFI International in assuring themselves, as well as third parties, that they are Trading in the Securities of TFI International only during periods in which it is reasonable for them to believe that all Material privileged information concerning TFI International has been disclosed publicly. 3. Reporting insider While the foregoing rules of conduct apply to ALL Insiders, only certain Insiders, the Reporting Insiders, are required to report their transactions on TFI International stock to the Securities authorities. Pursuant to National Instrument (1) Reporting Insider includes: a. the Chief Executive Officer ( CEO ), Chief Financial Officer ( CFO ) and Chief Operating Officer ( COO ) of TFI International Inc.; b. the CEO, CFO or COO of a Significant shareholder; c. The CEO, CFO and COO of a Major subsidiary of TFI International; d. A director of TFI International, a director of a Significant shareholder or of a Major subsidiary of TFI International; e. A person responsible for a principal business unit, division or function of TFI International; f. A Significant shareholder of TFI International Inc. (1) National Instrument came into force on April 30, 2010 and National Instrument was repealed. The full text of National Instrument is set out on the Ontario Securities Commission Website at 4

5 g. A management company that provides significant management or administrative services to TFI International or to a Major subsidiary of TFI International, every director of such management company, every CEO, CFO or COO of such management company, and every significant shareholder of such management company. h. Any other person that : (i) in the ordinary course receives or has access to material privileged information AND (ii) directly or indirectly exercise or has the ability to exercise, significant power or influence over the business, operations, capital or development of TFI International. Any person who becomes a Reporting Insider of TFI International must declare his/her holding or control over Securities of TFI International to the securities authorities within five (5) calendar days, whether or not this person owns any Securities. For that purpose, an initial insider report must be filed on SEDI. Furthermore, a Reporting Insider of TFI International must declare to the securities authorities any change (whatever the percentage may be) in their holding or control of the Securities of TFI International within five (5) calendar days of such change. For that purpose, an insider report must be filed on SEDI. You may contact Mrs. Josiane-M. Langlois (jlanglois@tfiintl.com) or visit SEDI s Website at for further information. 4. Infringement The Trading of Securities of TFI International by its Insiders may entail, in certain circumstances, a civil or penal liability under the securities laws. I confirm that I have read the Rules of Conduct of Insiders Respecting Trading of Securities of TFI International, set out above and understand their content and undertake to comply with them. signature name, please print title company date 5

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose

More information

HILLENBRAND INDUSTRIES INC

HILLENBRAND INDUSTRIES INC HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518

More information

FORM8-K HILLENBRAND,INC.

FORM8-K HILLENBRAND,INC. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015

More information

CORPORATE POLICY MANUAL. 1. SCOPE 1.1 Authority This policy is issued under the authority of the Senior Executive Team.

CORPORATE POLICY MANUAL. 1. SCOPE 1.1 Authority This policy is issued under the authority of the Senior Executive Team. C-37 CANADORE COLLEGE CORPORATE POLICY MANUAL TITLE: Substance Use Policy Recreational Cannabis and Alcohol EFFECTIVE DATE: October 12, 2018 1. SCOPE 1.1 Authority This policy is issued under the authority

More information

FORM8-K HILLENBRAND,INC.

FORM8-K HILLENBRAND,INC. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): February1,2016

More information

CSA Briefing Note Regarding Joint Application against the University and Re-Commencing Collection of CFS/CFS-O Fees

CSA Briefing Note Regarding Joint Application against the University and Re-Commencing Collection of CFS/CFS-O Fees CSA Briefing Note Regarding Joint Application against the University and Re-Commencing Collection of CFS/CFS-O Fees The CSA and University of Guelph undergraduate students have been members of the Canadian

More information

Employment Contract. This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available)

Employment Contract. This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available) Employment Contract This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available (NOTE: This is only one example of an employment contract. This example is meant

More information

Environmental, Health and Safety

Environmental, Health and Safety Environmental, Health and Safety Codes of Practice The Environmental, Health and Safety (EHS) Codes of Practice set forth Zimmer EHS requirements for our business functions and facilities worldwide. In

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

BVI Limited Partnership Hedge Funds: Calling Japan

BVI Limited Partnership Hedge Funds: Calling Japan BERMUDA BRITISH VIRGIN ISLANDS CAYMAN ISLANDS CYPRUS DUBAI HONG KONG LONDON MAURITIUS MOSCOW SÃO PAULO SINGAPORE conyersdill.com June 2012 BVI Limited Partnership Hedge Funds: Calling Japan Structuring

More information

WALGREENS BOOTS ALLIANCE, INC.

WALGREENS BOOTS ALLIANCE, INC. WALGREENS BOOTS ALLIANCE, INC. FORM 8-K (Current report filing) Filed 01/30/17 for the Period Ending 01/26/17 Address 108 WILMOT ROAD DEERFIELD, IL 60015 Telephone (847) 315-2500 CIK 0001618921 Symbol

More information

Gavi Alliance Conflict of Interest Policy Version 2.0

Gavi Alliance Conflict of Interest Policy Version 2.0 Version 2.0 DOCUMENT ADMINISTRATION VERSION NUMBER 1.0 APPROVAL PROCESS DATE Reviewed by: Gavi Governance Committee 15 April 2009 Approved by: Gavi Alliance Board 2.0 Prepared by: Legal and Governance

More information

DCP MIDSTREAM, LP FORM 8-K. (Current report filing) Filed 04/13/12 for the Period Ending 04/09/12

DCP MIDSTREAM, LP FORM 8-K. (Current report filing) Filed 04/13/12 for the Period Ending 04/09/12 DCP MIDSTREAM, LP FORM 8-K (Current report filing) Filed 04/13/12 for the Period Ending 04/09/12 Address 370 17TH STREET SUITE 2500 DENVER, CO, 80202 Telephone 303-595-3331 CIK 0001338065 Symbol DCP SIC

More information

Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia. -Broadens Roche Nicotinic Alpha-7 Alliance-

Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia. -Broadens Roche Nicotinic Alpha-7 Alliance- Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia -Broadens Roche Nicotinic Alpha-7 Alliance- -Secures Additional $5M Debt Financing to Support Phase 2a Trial-

More information

SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )

SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the

More information

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland

More information

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update Brisa Concessão Rodoviária 1Q 2017 Traffic Update 15 th May 2017 Disclaimer The information contained herein ( Information ) has been prepared by Brisa Concessão Rodoviária, S.A. ("BCR") and which, according

More information

Tamsulosin Hydrochloride 0.4 mg Capsule

Tamsulosin Hydrochloride 0.4 mg Capsule Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule

More information

GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS

GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS Version 1.0 GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS These General Terms and Conditions govern all sales of Publications, on paper and/or in digital format whether directly at the Sales Counter or

More information

$75K to $100K RA RA RA RA RA RA E $100K to $250K RA RA RA RA RA RA RA E Over $250K RA RA RA RA RA RA RA E RA

$75K to $100K RA RA RA RA RA RA E $100K to $250K RA RA RA RA RA RA RA E Over $250K RA RA RA RA RA RA RA E RA All contracts using non-standard terms and conditions must be reviewed by Legal. Note: the Deputy has the authority to sign for the Superintendent at any time. Standard Form Contracts RESPONSIBILITIES

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q 10-Q 1 v402511_10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934. For the

More information

TPN Investment Adviser Written Supervisory Procedures. December 2006

TPN Investment Adviser Written Supervisory Procedures. December 2006 TPN Investment Adviser Written Supervisory Procedures December 2006 TABLE OF CONTENTS I. Introduction 1 A. Compliance Program Policy 1 1. Compliance Program 2. Compliance Manual 3. Chief Compliance Officer

More information

Annex 1. CHOONG YEE HOW List of past directorships. 1. Hong Leong Islamic Bank Berhad. 2. Promilia Berhad. 3. HL Asset Management Pte Ltd

Annex 1. CHOONG YEE HOW List of past directorships. 1. Hong Leong Islamic Bank Berhad. 2. Promilia Berhad. 3. HL Asset Management Pte Ltd Page 1 of 3 Change - Announcement of Appointment::Appointment of Director and Group President & Chief Executive Officer Issuer & Securities Issuer/ Manager Securities Stapled Security GUOCOLAND LIMITED

More information

GAVI ALLIANCE STATUTES 26 March 2008

GAVI ALLIANCE STATUTES 26 March 2008 GAVI ALLIANCE STATUTES 26 March 2008 I. GENERAL PROVISIONS Article 1 Name An independent non-profit foundation within the meaning of Articles 80 et seq. of the Swiss Civil Code is referred to as the GAVI

More information

DARA Reports Year-End 2012 Financial Results

DARA Reports Year-End 2012 Financial Results April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,

More information

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE THIS NOTICE IS FOR YOUR INFORMATION ONLY. YOU ARE NOT REQUIRED TO TAKE ANY ACTION. Bursa Malaysia Securities Berhad ( Bursa Securities ) takes no responsibility for the contents of this Notice, makes no

More information

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. Rules of Membership 1. Introduction These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. The previously published

More information

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main

More information

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo

More information

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 VICAL INC FORM 8-K (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 Address 10390 PACIFIC CENTER COURT. SAN DIEGO, CA 92121-4340 Telephone 858-646-1100 CIK 0000819050 Symbol VICL SIC

More information

WALGREEN CO. FORM 8-K (Unscheduled Material Events) Filed 6/5/2006 For Period Ending 6/5/2006

WALGREEN CO. FORM 8-K (Unscheduled Material Events) Filed 6/5/2006 For Period Ending 6/5/2006 WALGREEN CO FORM 8-K (Unscheduled Material Events) Filed 6/5/2006 For Period Ending 6/5/2006 Address 200 WILMOT RD DEERFIELD, Illinois 60015 Telephone 847-940-2500 CIK 0000104207 Industry Retail (Drugs)

More information

NORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director

NORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director Robert Ullman Managing Director rullman@dinancapital.com 45.63.44 NORTH AMERICAN DERMATOLOGY M&A Activity and Valuation Trends Q4 205 William Downing Director wdowning@dinancapital.com 602.734.0682 Michael

More information

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

(4) Be as detailed as necessary to provide history of work performed; and:

(4) Be as detailed as necessary to provide history of work performed; and: www.omarfigueroa.com Page 66 of 278 (4) Be as detailed as necessary to provide history of work performed; and: (A) Include information adequate to identify any associated manufacturing facility (e.g.,

More information

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE The National Association to Advance Fat Acceptance is a nonprofit, member supported organization composed of determined

More information

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update -Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109

More information

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase

More information

DELTA DENTAL PREMIER

DELTA DENTAL PREMIER DELTA DENTAL PREMIER PARTICIPATING DENTIST AGREEMENT THIS AGREEMENT made and entered into this day of, 20 by and between Colorado Dental Service, Inc. d/b/a Delta Dental of Colorado, as first party, hereinafter

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

Investor Presentation

Investor Presentation ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an

More information

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; Top Line Data

More information

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15. [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS

More information

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track Conference Call

More information

ALCOHOL BEVERAGE PERMIT APPLICATION INSTRUCTIONS

ALCOHOL BEVERAGE PERMIT APPLICATION INSTRUCTIONS ALCOHOL BEVERAGE PERMIT APPLICATION INSTRUCTIONS Lewis-Clark State College developed the Entertainment and Alcohol Beverage Permit Application Process Guidelines (Guidelines) as an informational item to

More information

Committed to Environment, Health, & Safety

Committed to Environment, Health, & Safety Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,

More information

CITIZEN SUPPORT ORGANIZATION AGREEMENT

CITIZEN SUPPORT ORGANIZATION AGREEMENT CITIZEN SUPPORT ORGANIZATION AGREEMENT [NAME OF CSO] THIS AGREEMENT is made between the State of Florida Department of Environmental Protection ( DEP ), Division of Recreation and Parks, hereinafter called

More information

BYLAWS IOWA STATE AL-ANON FAMILY GROUPS ASSEMBLY, INC ARTICLE I CORPORATE NAME

BYLAWS IOWA STATE AL-ANON FAMILY GROUPS ASSEMBLY, INC ARTICLE I CORPORATE NAME BYLAWS OF IOWA STATE AL-ANON FAMILY GROUPS ASSEMBLY, INC ARTICLE I CORPORATE NAME The name of this Corporation, as set forth in its Articles of Incorporation, is IOWA STATE AL-ANON FAMILY GROUPS ASSEMBLY,

More information

For personal use only

For personal use only October 29 th, 2018 RotoGro to Acquire 100% of Canadian Lawful Cannabis License RotoGro to acquire 100% of the issued share capital of Supra THC from Valens GroWorks Corp. ( CSE:VGW ) Supra THC holds a

More information

QUESTIONNAIRE ANTI MONEY LAUNDERING (Including Counter Terrorist Financing, Financial Sanctions Monitoring, KYC)

QUESTIONNAIRE ANTI MONEY LAUNDERING (Including Counter Terrorist Financing, Financial Sanctions Monitoring, KYC) QUESTIOAIRE ATI MOE LAUDERIG (Including Counter Terrorist Financing, Financial Sanctions Monitoring, KC) Please respond to the following questionnaire by filling the columns with appropriate details or

More information

THE COMPLEXITIES OF M&A IN THE CANNABIS INDUSTRY. Presented by Robert T. Hoban, Esq.

THE COMPLEXITIES OF M&A IN THE CANNABIS INDUSTRY. Presented by Robert T. Hoban, Esq. THE COMPLEXITIES OF M&A IN THE CANNABIS INDUSTRY Presented by Robert T. Hoban, Esq. Hoban Law Group! Formed in 2008, practicing exclusively in cannabis since 2011! 36 attorneys licensed in 40+ states!

More information

Oncolytics Biotech Inc. Announces Third Quarter 2010 Results

Oncolytics Biotech Inc. Announces Third Quarter 2010 Results November 10, 2010 Oncolytics Biotech Announces Third Quarter 2010 Results CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Oncolytics Biotech (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced

More information

DW PENNICHUCK EAST UTILITY, INC. Petition for Franchise Approval and Rates. Order Nisi Approving Franchise and Rate Petition

DW PENNICHUCK EAST UTILITY, INC. Petition for Franchise Approval and Rates. Order Nisi Approving Franchise and Rate Petition DW 03-023 PENNICHUCK EAST UTILITY, INC. Petition for Franchise Approval and Rates Order Nisi Approving Franchise and Rate Petition O R D E R N O. 24,264 January 9, 2004 I. BACKGROUND Pennichuck East Utility,

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

GENERAL INFORMATION AND INSTRUCTIONS

GENERAL INFORMATION AND INSTRUCTIONS NON-PARTICIPATING MANUFACTURER CERTIFICATION FOR LISTING ON OREGON DIRECTORY GENERAL INFORMATION AND INSTRUCTIONS Who is required to file this Certification? Any tobacco product manufacturer who is a non-participating

More information

OVERSEAS SCHOOL OF COLOMBO SCHOOL COMMUNITY NETWORK (SCN) CONSTITUTION

OVERSEAS SCHOOL OF COLOMBO SCHOOL COMMUNITY NETWORK (SCN) CONSTITUTION OVERSEAS SCHOOL OF COLOMBO SCHOOL COMMUNITY NETWORK (SCN) CONSTITUTION Introduction/Background: This updated constitution reflects the needs of the school community to define the role of the SCN as it

More information

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator

More information

Third-quarter results 2013

Third-quarter results 2013 Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen

More information

For An Act To Be Entitled. Subtitle

For An Act To Be Entitled. Subtitle 0 0 State of Arkansas INTERIM STUDY PROPOSAL 0-0th General Assembly A Bill DRAFT JMB/JMB Second Extraordinary Session, 0 SENATE BILL By: Senator J. Hutchinson Filed with: Arkansas Legislative Council pursuant

More information

Standards of Conduct for Transmission Providers

Standards of Conduct for Transmission Providers Standards of Conduct for Transmission Providers Posted and Effective as of December 30, 2016 Puget Sound Energy ( PSE ) is a public utility that owns, operates, and controls facilities used for the transmission

More information

Consultancy Support Services for the Procurement of LEU for the establishment of the IAEA LEU Bank

Consultancy Support Services for the Procurement of LEU for the establishment of the IAEA LEU Bank Statement of Work Services for the Procurement for the establishment of the IAEA LEU Bank 14 June 2016 Page 1 of 8 Statement of Work (SOW) Market Research and Procurement - 1. Introduction... 3 2. General

More information

Policy of Conflict of Interest in Clinical Research

Policy of Conflict of Interest in Clinical Research Policy of Conflict of Interest in Clinical Research The Japan Society of Hepatology Academic-industrial collaboration has been assigned as a national strategy to assist in establishing Japan as a nation

More information

Inovio Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

Inovio Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

CARIBX (UK) LIMITED. Environmental, Health and Safety Management System. Revision: 00 APRIL 2011

CARIBX (UK) LIMITED. Environmental, Health and Safety Management System. Revision: 00 APRIL 2011 CARIBX (UK) LIMITED Environmental, Health and Safety Management System Revision: 00 APRIL 2011 Document Details and Issue Record Rev No. Details Date Author Checked Text 00 Draft 01/04/2011 CJMD Calcs

More information

Investing in Dental Practice Management: Key Issues and Notable Transactions

Investing in Dental Practice Management: Key Issues and Notable Transactions Investing in Dental Practice Management: Key Issues and Notable Transactions SCOTT BECKER, PARTNER 312.750.6016 sbecker@mcguirewoods.com 77 West Wacker Drive, Suite 4100 Chicago, Illinois 60601 LAURALEE

More information

MINISTRY OF PUBLIC HEALTH

MINISTRY OF PUBLIC HEALTH MINISTRY OF THE INTERIOR MINISTRY OF FOREIGN AFFAIRS MINISTRY OF THE ECONOMY AND FINANCE MINISTRY OF NATIONAL DEFENSE MINISTRY OF EDUCATION AND CULTURE MINISTRY OF TRANSPORTATION AND PUBLIC WORKS MINISTRY

More information

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Boiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income.

Boiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income. 2008 FIRST QUARTER ACTIVITY IFRS - In thousands of Euros 2007 2007 2008 constant France (1) 0,000 66,087 65,728-0.5% -0.5% Europe excluding France 0,000 33,221 41,346 +24.5% +23.2% North America 0,000

More information

Avenue Therapeutics, Inc. May 2017

Avenue Therapeutics, Inc. May 2017 Avenue Therapeutics, Inc. May 2017 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the safe

More information

Re: Bill S-5, An Act to amend the Tobacco Act and the Non-smokers Health Act and to make consequential amendments to other Acts

Re: Bill S-5, An Act to amend the Tobacco Act and the Non-smokers Health Act and to make consequential amendments to other Acts 655 Third Avenue, 10th Floor, New York, NY 10017-5646, USA t: +1-212-642-1776 f: +1-212-768-7796 inta.org esanzdeacedo@inta.org The Honorable Kelvin Kenneth Ogilvie Chair Standing Committee on Social Affairs,

More information

CANNABIS MANAGEMENT CORPORATION REGULATIONS

CANNABIS MANAGEMENT CORPORATION REGULATIONS c t CANNABIS MANAGEMENT CORPORATION REGULATIONS PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this regulation, current to August 11, 2018. It is intended

More information

Poison Puts: Corporate Governance Structure or Mechanism for Shifting Risk? Webinar October 5, 2015

Poison Puts: Corporate Governance Structure or Mechanism for Shifting Risk? Webinar October 5, 2015 Poison Puts: Corporate Governance Structure or Mechanism for Shifting Risk? Webinar October 5, 2015 1 Agenda Introductions Research Review IRRCi Perspective Q&A 2 Webinar Logistics! Attendees in listen

More information

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018 Guidance for Municipalities Regarding Marijuana for Adult Use January 2018 The following information is provided to assist municipalities by addressing questions related to the regulation of marijuana

More information

Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA (parathyroid hormone)

Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA (parathyroid hormone) Press Release www.shire.com Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA (parathyroid hormone) Dublin, Ireland January 23, 2015 Shire plc (LSE: SHP, NASDAQ: SHPG) notes

More information

Development Bank of Southern Africa Amendment Bill [B ]

Development Bank of Southern Africa Amendment Bill [B ] Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Select Committee on Finance National Council of Provinces 21 October 2014 Presenters : Mr Ben Mokheseng Deputy Director: Asset

More information

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,

More information

FORM 6-K. SECURITIES AND EXCHANGE COMMISSION Washington D.C

FORM 6-K. SECURITIES AND EXCHANGE COMMISSION Washington D.C FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2009 Commission

More information

For personal use only

For personal use only Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development

More information

CIGARETTE TAX, TOBACCO ESCROW FUNDS MASTER SETTLEMENT AGREEMENT, TOBACCO PRODUCTS TAX

CIGARETTE TAX, TOBACCO ESCROW FUNDS MASTER SETTLEMENT AGREEMENT, TOBACCO PRODUCTS TAX DEPARTMENT OF REVENUE Tax Group CIGARETTE TAX, TOBACCO ESCROW FUNDS MASTER SETTLEMENT AGREEMENT, TOBACCO PRODUCTS TAX 1 CCR 201-7 [Editor s Notes follow the text of the rules at the end of this CCR Document.]

More information

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP ARTICLE I NAME AND LOGO CONSTITUTION The name of the Society is Cameroon Radiological Protection Society which is created in 28 th September 2012 may be referred to in abbreviated form as CRPS. The logo

More information

No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the NOTIFICATION. In supersession of this Department s Office Order of even number

No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the NOTIFICATION. In supersession of this Department s Office Order of even number Government of Himachal Pradesh Department of Ayurveda No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the 31-8-2009 NOTIFICATION In supersession of this Department s Office Order of even number dated 5 th February,

More information

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY

INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY August 24, 2012 1. Purpose Public confidence and the reputation of the company are valuable business assets that Inovio strives to

More information

For personal use only

For personal use only ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting

More information

Conflict of Interest Policy

Conflict of Interest Policy Revised 10/13/2016 Conflict of Interest Policy All AMIA leaders have an obligation to make decisions and conduct affairs of the organization based, first and foremost, upon the desire to promote AMIA and

More information

SCOTIABANK ANTI-MONEY LAUNDERING (AML) / ANTI-TERRORIST FINANCING (ATF) QUESTIONNAIRE

SCOTIABANK ANTI-MONEY LAUNDERING (AML) / ANTI-TERRORIST FINANCING (ATF) QUESTIONNAIRE Bank s name: Address: SWIFT CODE: SCOTIABANK ANTI-MONEY LAUNDERING (AML) / ANTI-TERRORIST FINANCING (ATF) QUESTIONNAIRE Website: I. Financial Institution Information 1. a) Is your institution (or parent

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

Do not edit or delete any questions from this application. Doing so will result in immediate disqualification of your request.

Do not edit or delete any questions from this application. Doing so will result in immediate disqualification of your request. AIDS Walk of Oklahoma City, Inc. Request for Proposal (RFP) 2018 Proposal Application (for funding year 2019) Deadline: October 31, 2018 NOT VALID AFTER OCTOBER 31, 2018 General instructions can be downloaded

More information

Consob Net Short Positions ( NSP ) Notification System. User Manual

Consob Net Short Positions ( NSP ) Notification System. User Manual Consob Net Short Positions ( NSP ) Notification System User Manual Contents 1. Registration of a new user... 2 2. Lost password regeneration... 3 3. Changing user details... 3 4. NSP management overview...

More information

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET

Clovis Oncology Announces Q Operating Results and Corporate Update. November 3, :05 PM ET Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update November 3, 2016 4:05 PM ET Rucaparib New Drug Application (NDA) accepted for Priority Review in the treatment of advanced BRCA-mutant

More information

Avenue Therapeutics, Inc. August 2016

Avenue Therapeutics, Inc. August 2016 Avenue Therapeutics, Inc. August 2016 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the safe

More information

(City, State, Zip Code)

(City, State, Zip Code) This Partner Agency Agreement, dated this day of, 2015, is between COMMUNITY FOOD SHARE, INC. (CFS), whose address is 650 South Taylor Avenue, Louisville, CO 80027, and (Partner Agency) whose address is

More information

Industry experience in consortium i.e. from BEE party or non-bee partners

Industry experience in consortium i.e. from BEE party or non-bee partners A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:

More information

For personal use only

For personal use only Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by

More information

Avenue Therapeutics, Inc. September 2016

Avenue Therapeutics, Inc. September 2016 Avenue Therapeutics, Inc. September 2016 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the

More information

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK Small-Cap Research November 16, 2017 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final

More information

BTM RESOURCES BERHAD

BTM RESOURCES BERHAD THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IF YOU ARE IN ANY DOUBT AS TO THE COURSE OF ACTION YOU SHOULD TAKE, YOU SHOULD CONSULT YOUR STOCKBROKER, BANK MANAGER, SOLICITOR, ACCOUNTANT

More information

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development

More information

Government Gazette REPUBLIC OF SOUTH AFRICA

Government Gazette REPUBLIC OF SOUTH AFRICA Government Gazette REPUBLIC OF SOUTH AFRICA Vol. 523 Cape Town 9 January 2009 No. 31790 THE PRESIDENCY No. 23 9 January 2009 It is hereby notified that the President has assented to the following Act,

More information

Procurement Policy. May 2016 (as amended on 1 July 2017)

Procurement Policy. May 2016 (as amended on 1 July 2017) Procurement Policy May 2016 (as amended on 1 July 2017) Contents 1 Introduction... 3 2 Terms and Definitions... 3 3 Scope... 3 4 General Principles of ESM Procurement... 4 5 Contract Value and Thresholds...

More information

APPLICABILITY/ACCOUNTABILITY: This policy applies to all persons and activities on campus. POLICY STATEMENT:

APPLICABILITY/ACCOUNTABILITY: This policy applies to all persons and activities on campus. POLICY STATEMENT: SUBJECT: Effective Date: Policy Number: Alcoholic Beverages on Campus 1-20-2010 3-115.1 Supersedes: Page Of 8-12-09 1 9 Responsible Authority: Vice President for Administration and Finance Vice President

More information

PUBLIC SERVICE COMMISSION OF THE DISTRICT OF COLUMBIA 1325 G STREET N.W., SUITE 800 WASHINGTON, D.C ORDER

PUBLIC SERVICE COMMISSION OF THE DISTRICT OF COLUMBIA 1325 G STREET N.W., SUITE 800 WASHINGTON, D.C ORDER PUBLIC SERVICE COMMISSION OF THE DISTRICT OF COLUMBIA 1325 G STREET N.W., SUITE 800 WASHINGTON, D.C. 20005 ORDER June 24, 2016 FORMAL CASE NO. 1017, IN THE MATTER OF THE DEVELOPMENT AND DESIGNATION OF

More information